IICAX
Price
$12.29
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
VTSAX
Price
$144.14
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

IICAX vs VTSAX

Header iconIICAX vs VTSAX Comparison
Open Charts IICAX vs VTSAXBanner chart's image
AMF Large Cap Equity AMF
Price$12.29
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Adm
Price$144.14
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
IICAX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IICAX vs. VTSAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IICAX is a Buy and VTSAX is a Buy.

FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.73T vs. IICAX (53.9M). VTSAX pays higher dividends than IICAX: VTSAX (1.35) vs IICAX (0.38). IICAX was incepted earlier than VTSAX: IICAX (71 years) vs VTSAX (24 years). IICAX is a more actively managed with annual turnover of: 8.00 vs. VTSAX (2.00). IICAX has a lower initial minimum investment than VTSAX: IICAX (2500) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 33.39 vs. IICAX (19.53). VTSAX return over 5 years is better than : 87.46 vs. IICAX (47.01).
IICAXVTSAXIICAX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence71 years24 years-
Gain YTD22.29324.89190%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets53.9M1.73T0%
Annual Yield % from dividends0.381.3528%
Returns for 1 year19.5333.3958%
Returns for 3 years7.4522.8233%
Returns for 5 years47.0187.4654%
Returns for 10 years14.93194.078%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERX50.580.83
+1.67%
Vertex
IT551.801.14
+0.21%
Gartner
PDFS31.88-0.95
-2.89%
PDF Solutions
KMDA6.06-0.21
-3.35%
Kamada Ltd
VRCA0.84-0.08
-8.37%
Verrica Pharmaceuticals